
1. j crit care. 2019 jun;51:99-104. doi: 10.1016/j.jcrc.2019.02.019. epub 2019 feb
13.

severe acute respiratory distress syndrome (ards) induced human adenovirus
b21: report 2 cases literature review.

pfortmueller ca(1), barbani mt(2), schefold jc(3), hage e(4), heim a(5), zimmerli
s(6).

author information: 
(1)department intensive care, inselspital, bern university hospital,
university bern, freiburgstrasse 10, 3010 bern, switzerland. electronic
address: carmen.pfortmueller@insel.ch.
(2)institute infectious diseases, university bern, friedbuehlstrasse 51,
3010 bern, switzerland. electronic address: mariateresa.barbani@ifik.unibe.ch.
(3)department intensive care, inselspital, bern university hospital,
university bern, freiburgstrasse 10, 3010 bern, switzerland. electronic
address: joerg.schefold@insel.ch.
(4)institute virology, hannover medical school, hannover, germany.
(5)institute virology, hannover medical school, hannover, germany. electronic 
address: heim.albert@mh-hannover.de.
(6)institute infectious diseases, university bern, friedbuehlstrasse 51,
3010 bern, switzerland; department infectious diseases, inselspital, bern
university hospital, university bern, freiburgstrasse 10, 3010 bern,
switzerland. electronic address: stefan.zimmerli@insel.ch.

severe pneumonia ards caused human adenovirus b21 infections (hadv-b21) is
a rare, devastating disease rapid progression multiorgan failure
and death. however, cases reported far. infections appear
associated increased disease severity higher mortality infected
critically ill patients. possible factors contributing infection are
underlying psychiatric disease resulting institutionalization respective
patients, polytoxicomania. controlled data therapy severe
adenovirus infections lacking remains experimental. conclusion, data
on hadv-b21 infections causing severe pneumonia ards scarce. controlled
clinical trials therapy adenovirus pneumonia non existent thus 
there established therapy far. icu physicians aware this
potentially devastating disease studies needed.

copyright Â© 2019 elsevier inc. rights reserved.

doi: 10.1016/j.jcrc.2019.02.019 
pmcid: pmc7172394
pmid: 30798099  [indexed medline]

